MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,483,000 | -47.6% | 88,952 | -35.3% | 0.00% | -33.3% |
Q3 2016 | $2,829,000 | -32.3% | 137,450 | +0.6% | 0.00% | -25.0% |
Q2 2016 | $4,181,000 | -17.1% | 136,647 | +1.4% | 0.00% | -20.0% |
Q1 2016 | $5,046,000 | -9.8% | 134,808 | +4.0% | 0.01% | -16.7% |
Q4 2015 | $5,596,000 | +40.2% | 129,656 | +21.8% | 0.01% | +50.0% |
Q3 2015 | $3,991,000 | +18.7% | 106,485 | +7.7% | 0.00% | +33.3% |
Q2 2015 | $3,361,000 | +770.7% | 98,889 | +808.1% | 0.00% | – |
Q1 2015 | $386,000 | -36.0% | 10,890 | -38.5% | 0.00% | -100.0% |
Q4 2014 | $603,000 | -27.3% | 17,694 | -17.8% | 0.00% | 0.0% |
Q3 2014 | $830,000 | -67.3% | 21,513 | -67.0% | 0.00% | -50.0% |
Q2 2014 | $2,535,000 | -96.2% | 65,132 | -96.7% | 0.00% | -97.0% |
Q1 2014 | $67,250,000 | +69.8% | 1,966,941 | +4.2% | 0.07% | +73.7% |
Q4 2013 | $39,602,000 | -8.1% | 1,887,586 | +2.9% | 0.04% | -11.6% |
Q3 2013 | $43,114,000 | -0.7% | 1,834,645 | +13.5% | 0.04% | -6.5% |
Q2 2013 | $43,436,000 | – | 1,616,543 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |